Effect of adjuvant perioperative desmopressin in locally advanced canine mammary carcinoma and its relation to histologic grade

Journal of the American Animal Hospital Association

Volumn 47, Issue 1, 2011, Pages 21-27

  Hermo, Guillermo A ^a,d   Turic, Esteban ^b   Angelico, Daniel ^b   Scursoni, Alejandra M ^c   Gomez, Daniel E ^a   Gobello, Cristina ^d   Alonso, Daniel F ^b  

^a UNIVERSIDAD NACIONAL DE QUILMES   (Argentina)

^b Bernal Medical Offices ^*

^c UNIVERSIDAD NACIONAL DE LA PLATA   (Argentina)

^d Argentine Association of Veterinary Parasitology (AAPAVET)   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ARGIPRESSIN[1 DEAMINO]; HEMOSTATIC AGENT;

ANIMAL; ANIMAL DISEASE; ARTICLE; CANCER STAGING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOG; DOG DISEASE; EXPERIMENTAL NEOPLASM; FEMALE; MASTECTOMY; MORTALITY; PATHOLOGY; PERIOPERATIVE PERIOD; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ANIMALS; DEAMINO ARGININE VASOPRESSIN; DOG DISEASES; DOGS; FEMALE; HEMOSTATICS; MAMMARY NEOPLASMS, ANIMAL; MASTECTOMY; NEOPLASM STAGING; PERIOPERATIVE CARE; TREATMENT OUTCOME;

ANIMALIA; CANIDAE; CANIS FAMILIARIS;

EID: 78650828398     PISSN: 15473317     EISSN: 15473317     Source Type: Journal    
DOI: 10.5326/JAAHA-MS-5509     Document Type: Article

References (32)

1. Egenvall A, Bonnett BN, Ohagen P, et al. Incidence of and survival after mammary tumors in a population of over 80,000 insured female dogs in Sweden from 1995 to 2002. Prev Vet Med 2005;69(1-2):109-27.
2. Moe L. Population-based incidence of mammary tumours in some dog breeds. J Reprod Fertil Suppl 2001;57:439-43.
3. Morrison WB. Canine and feline mammary tumors. In: Morrison WB, editor. Cancer in dogs and cats: medical and surgical management. Baltimore, MD: Williams and Wilkins; 1998:591-6.
4. White RA. Mammary gland surgery. In: Slatter DH, ed. Textbook of small animal surgery. 3rd ed. Philadelphia: WB Saunders; 2002:349-51.
5. Rutteman GR. Mammary tumors in dog. In: Kirk RW, ed. Current veterinary therapy XIII. Small animal practice. Philadelphia: WB Saunders; 1999:518-22.
6. Ogilvie GK, Reynolds HA, Richardson RC, et al. Phase II evaluation of doxorubicin for treatment of various canine neoplasms. J Am Vet Med Assoc 1989;195(11):1580-3.
7. Karayannopoulou M, Kaldrymidou E, Constantinidis TC, et al. Adjuvant post-operative chemotherapy in bitches with mammary cancer. J Vet Med A Physiol Pathol Clin Med 2001;48(2):85-96.
8. Poirier VJ, Hershey AE, Burgess KE, et al. Efficacy and toxicity of paclitaxel (Taxol) for the treatment of canine malignant tumors. J Vet Intern Med 2004;18(2):219-22.
9. Rutteman GR, Withrow SJ, McEwen EG. Tumors of the mammary gland. In: Withrow SJ, Mc Ewen EG, eds. Small animal clinical oncology. 3rd ed. Philadelphia: WB Saunders; 2001:455-77.
10. Karayannopoulou M, Kaldrymidou E, Constantinidis TC, et al. Histological grading and prognosis in dogs with mammary carcinomas: application of a human grading method. J Comp Pathol 2005;133(4):246-52.
11. Hermo GA, Torres P, Ripoll GV, et al. Perioperative desmopressin prolongs survival in surgically treated bitches with mammary gland tumours: a pilot study. Vet J 2008;178(1):103-8.
12. Alonso DF, Skilton G, Farías EF, et al. Antimetastatic effect of desmopressin in a mouse mammary tumor model. Breast Cancer Res Treat 1999;57(3):271-5.
13. Giron S, Tejera AM, Ripoll GV, et al. Desmopressin inhibits lung and lymph node metastasis in a mouse mammary carcinoma model of surgical manipulation. J Surg Oncol 2002;81(1):38-44.
14. Authement JM, Boudrieau RJ, Kaplan PM. Transient, traumatically induced, central diabetes insipidus in a dog. J Am Vet Med Assoc 1989;194(5):683-5.
15. Papich MG. Table of common drugs: approximate dosages. In: Bonagura JD, ed. Kirk's current veterinary therapy XIII. Small animal practice. Philadelphia: WB Saunders; 2000:1241-64.
16. Richardson DW, Robinson AG. Desmopressin. Ann Intern Med 1985;103(2):228-39.
17. Kaufmann JE, Vischer UM. Cellular mechanisms of the hemostatic effects of desmopressin (DDAVP). J Thromb Haemost 2003;1(4):682-9.
18. Mannucci PM. Desmopressin (DDAVP) in the treatment of bleeding disorders: the first 20 years. Blood 1997;90(7):2515-21.
19. Wilkinson GT. The treatment of mammary tumors in the bitch and a comparison with the cat. Vet Rec 1971;89(1):13-6.
20. Withrow SJ. Symposium on surgical techniques in small animal practice. Surgical management of canine mammary tumors. Vet Clin North Am 1975;5(3):495-506.
21. Misdorp W, Else RW, Hellmen E, et al. Histological classification of mammary tumor of the dog and the cat. Vol VII. Washington, DC: Armed Forces Institute of Pathology and American Registry of Pathology and the World Health Organization Collaborating Center for Worldwide Reference on Comparative Oncology; 1999:58-9.
22. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathol 1991;19(5):403-10.
23. Gilbertson SR, Kurzman ID, Zachrau RE, et al. Canine mammary epithelial neoplasms: biologic implications of morphologic characteristics assessed in 232 dogs. Vet Pathol 1983;20(2):127-42.
24. Castagnaro M, Casalone C, Bozzetta E, et al. Tumour grading and the one-year post-surgical prognosis in feline mammary carcinomas. J Comp Pathol 1998;119(3):263-75.
25. Reis AL, Carvalheira J, Schmitt FC, et al. Immunohistochemical study of the expression of E-cadherin in canine mammary tumours. Vet Rec 2003;152(20):621-4.
26. Kaplan EL, Meier E. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
27. Terraube V, Pendu R, Baruch D, et al. Increased metastatic potential of tumor cells in von Willebrand factor-deficient mice. J Thromb Haemost 2006;4(3):519-26.
28. Terraube V, Marx I, Denis CV. Role of von Willebrand factor in tumor metastasis. Thromb Res 2007;120(Suppl 2):S64-70.
29. North WG. Gene regulation of vasopressin and vasopressin receptors in cancer. Exp Physiol 2000;85:27S-40S.
30. Ripoll GV, Giron S, Krzymuski MJ, et al. Antitumor effects of desmopressin in combination with chemotherapeutic agents in a mouse model of breast cancer. Anticancer Res 2008;28(5A):2607-11.
31. Keegan BP, Akerman BL, Péqueux C, et al. Provasopressin expression by breast cancer cells: implications for growth and novel treatment strategies. Breast Cancer Res Treat 2006;95(3):265-77.
32. Taylor AH, Ang VT, Jenkins JS, et al. Interaction of vasopressin and oxytocin with human breast carcinoma cells. Cancer Res 1990; 50(24):7882-6.